Lataa...
维吾尔族肺腺癌患者的EGFR基因突变分析
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR), a transmembrane protein, is a member of the tyrosine kinase family. Gefitinib, an EGFR tyrosine-kinase inhibitors, has shown a high response rate in the treatment of lung cancer in patients with EGFR mutation. However, significant di...
Tallennettuna:
| Julkaisussa: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
中国肺癌杂志编辑部
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000386/ https://ncbi.nlm.nih.gov/pubmed/23425899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2013.02.04 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|